Orchestra BioMed Holdings (OBIO) Return on Equity (2022 - 2025)
Historic Return on Equity for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 3.41%.
- Orchestra BioMed Holdings' Return on Equity fell 21700.0% to 3.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.41%, marking a year-over-year decrease of 21700.0%. This contributed to the annual value of 1.21% for FY2024, which is 4200.0% down from last year.
- According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Return on Equity is 3.41%, which was down 21700.0% from 8.13% recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Return on Equity ranged from a high of 0.47% in Q2 2023 and a low of 8.13% during Q2 2025
- Its 4-year average for Return on Equity is 1.88%, with a median of 1.16% in 2024.
- As far as peak fluctuations go, Orchestra BioMed Holdings' Return on Equity soared by 7400bps in 2023, and later tumbled by -70500bps in 2025.
- Over the past 4 years, Orchestra BioMed Holdings' Return on Equity (Quarter) stood at 1.41% in 2022, then surged by 52bps to 0.67% in 2023, then crashed by -130bps to 1.54% in 2024, then crashed by -122bps to 3.41% in 2025.
- Its last three reported values are 3.41% in Q3 2025, 8.13% for Q2 2025, and 2.66% during Q1 2025.